Goldman Sachs Maintains Neutral on Doximity, Lowers Price Target to $24
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Goldman Sachs analyst David Roman maintains Doximity (NYSE:DOCS) with a Neutral and lowers the price target from $28 to $24.
Goldman Sachs analyst David Roman maintains Doximity (NYSE:DOCS) with a Neutral and lowers the price target from $28 to $24.